These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 11594921)

  • 1. Clinical correlates of action tremor in Parkinson disease.
    Louis ED; Levy G; Côte LJ; Mejia H; Fahn S; Marder K
    Arch Neurol; 2001 Oct; 58(10):1630-4. PubMed ID: 11594921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subthalamic nucleus stimulation for Parkinson disease: benefits observed in levodopa-intolerant patients.
    Katayama Y; Kasai M; Oshima H; Fukaya C; Yamamoto T; Ogawa K; Mizutani T
    J Neurosurg; 2001 Aug; 95(2):213-21. PubMed ID: 11780890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substantia Nigra Volume Dissociates Bradykinesia and Rigidity from Tremor in Parkinson's Disease: A 7 Tesla Imaging Study.
    Poston KL; Ua Cruadhlaoich MAI; Santoso LF; Bernstein JD; Liu T; Wang Y; Rutt B; Kerchner GA; Zeineh MM
    J Parkinsons Dis; 2020; 10(2):591-604. PubMed ID: 32250317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors predicting response to dopaminergic treatment for resting tremor of Parkinson's disease.
    Sung YH; Chung SJ; Kim SR; Lee MC
    Mov Disord; 2008 Jan; 23(1):137-40. PubMed ID: 17987649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Action tremor in Parkinson's disease: frequency and relationship to motor and non-motor signs.
    Gigante AF; Bruno G; Iliceto G; Guido M; Liuzzi D; Mancino PV; De Caro MF; Livrea P; Defazio G
    Eur J Neurol; 2015 Feb; 22(2):223-8. PubMed ID: 25363380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of stage of Parkinson's disease at the onset of levodopa therapy on development of motor complications.
    Kostić VS; Marinković J; Svetel M; Stefanova E; Przedborski S
    Eur J Neurol; 2002 Jan; 9(1):9-14. PubMed ID: 11784369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of motor and nonmotor features of Parkinson's disease and their response to treatment.
    Vu TC; Nutt JG; Holford NH
    Br J Clin Pharmacol; 2012 Aug; 74(2):267-83. PubMed ID: 22283961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of Parkinson's disease following thalamic deep brain stimulation for tremor.
    Tarsy D; Scollins L; Corapi K; O'Herron S; Apetauerova D; Norregaard T
    Stereotact Funct Neurosurg; 2005; 83(5-6):222-7. PubMed ID: 16534254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motor asymmetry over time in Parkinson's disease.
    Miller-Patterson C; Buesa R; McLaughlin N; Jones R; Akbar U; Friedman JH
    J Neurol Sci; 2018 Oct; 393():14-17. PubMed ID: 30096567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of motor fluctuations in Parkinson's disease.
    Widnell K
    Mov Disord; 2005; 20 Suppl 11():S17-22. PubMed ID: 15822108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The patient's perspective: The effect of levodopa on Parkinson symptoms.
    Zach H; Dirkx M; Pasman JW; Bloem BR; Helmich RC
    Parkinsonism Relat Disord; 2017 Feb; 35():48-54. PubMed ID: 27919585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Motor Syndrome of Parkinson's Disease.
    Erro R; Stamelou M
    Int Rev Neurobiol; 2017; 132():25-32. PubMed ID: 28554410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-emergent tremor in Parkinson's disease: the effect of dopaminergic treatment.
    Belvisi D; Conte A; Cutrona C; Costanzo M; Ferrazzano G; Fabbrini G; Berardelli A
    Eur J Neurol; 2018 Jun; 25(6):799-804. PubMed ID: 29512863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine-responsive and dopamine-resistant resting tremor in Parkinson disease.
    Zach H; Dirkx MF; Roth D; Pasman JW; Bloem BR; Helmich RC
    Neurology; 2020 Sep; 95(11):e1461-e1470. PubMed ID: 32651292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of two motor subtype classifications in de novo Parkinson's disease.
    Choi SM; Kim BC; Cho BH; Kang KW; Choi KH; Kim JT; Lee SH; Park MS; Kim MK; Cho KH
    Parkinsonism Relat Disord; 2018 Sep; 54():74-78. PubMed ID: 29703644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson's disease.
    Stocchi F; Rabey JM
    Eur J Neurol; 2011 Dec; 18(12):1373-8. PubMed ID: 21895884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of neuroleptic-induced parkinsonism.
    Hassin-Baer S; Sirota P; Korczyn AD; Treves TA; Epstein B; Shabtai H; Martin T; Litvinjuk Y; Giladi N
    J Neural Transm (Vienna); 2001; 108(11):1299-308. PubMed ID: 11768628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosing Parkinson's disease using videotaped neurological examinations: validity and factors that contribute to incorrect diagnoses.
    Louis ED; Levy G; Côte LJ; Mejia H; Fahn S; Marder K
    Mov Disord; 2002 May; 17(3):513-7. PubMed ID: 12112199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Segmental progression of cardinal motor symptoms in Parkinson's disease: a pilot study suggesting a practical approach to rate disease course in the early stages.
    Picillo M; Amboni M; Erro R; Vitale C; Longo K; Pellecchia MT; Cozzolino A; Moccia M; Allocca R; Barone P
    Parkinsonism Relat Disord; 2013 Dec; 19(12):1143-8. PubMed ID: 24041938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease.
    Tison F; Yekhlef F; Chrysostome V; Balestre E; Quinn NP; Poewe W; Wenning GK
    Mov Disord; 2002 Jul; 17(4):701-9. PubMed ID: 12210859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.